A Case of Phage Therapy against Pandrug-Resistant <i>Achromobacter xylosoxidans</i> in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient

A Case of Phage Therapy against Pandrug-Resistant <i>Achromobacter xylosoxidans</i> in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient

Bacteriophages are a promising therapeutic strategy among cystic fibrosis and lung-transplanted patients, considering the high frequency of colonization/infection caused by pandrug-resistant bacteria. However, little clinical data are available regarding the use of phages for infections with <i&g...

Full description

Bibliographic Details
Main Authors: David Lebeaux, Maia Merabishvili, Eric Caudron, Damien Lannoy, Leen Van Simaey, Hans Duyvejonck, Romain Guillemain, Caroline Thumerelle, Isabelle Podglajen, Fabrice Compain, Najiby Kassis, Jean-Luc Mainardi, Johannes Wittmann, Christine Rohde, Jean-Paul Pirnay, Nicolas Dufour, Stefan Vermeulen, Yannick Gansemans, Filip Van Nieuwerburgh, Mario Vaneechoutte
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Viruses
Subjects:
cystic fibrosis
lung transplantation
antibiotic resistance
<i>Achromobacter xylosoxidans</i>
bacteriophage therapy
Online Access:https://www.mdpi.com/1999-4915/13/1/60

Similar Items

Similar Items